416 related articles for article (PubMed ID: 35127375)
21. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
22. From design to clinic: Engineered peptide nanomaterials for cancer immunotherapy.
Du JJ; Su Z; Yu H; Qin S; Wang D
Front Chem; 2022; 10():1107600. PubMed ID: 36733612
[TBL] [Abstract][Full Text] [Related]
23. Gold nanoparticles-mediated photothermal therapy and immunotherapy.
Liu Y; Crawford BM; Vo-Dinh T
Immunotherapy; 2018 Sep; 10(13):1175-1188. PubMed ID: 30236026
[TBL] [Abstract][Full Text] [Related]
24. Designing and Engineering of Nanocarriers for Bioapplication in Cancer Immunotherapy.
Li Y; Zhang X; Liu X; Pan W; Li N; Tang B
ACS Appl Bio Mater; 2020 Dec; 3(12):8321-8337. PubMed ID: 35019605
[TBL] [Abstract][Full Text] [Related]
25. Nanoparticle-Based Nanomedicines to Promote Cancer Immunotherapy: Recent Advances and Future Directions.
Liu J; Zhang R; Xu ZP
Small; 2019 Aug; 15(32):e1900262. PubMed ID: 30908864
[TBL] [Abstract][Full Text] [Related]
26. Mitochondria-Targeting Immunogenic Cell Death Inducer Improves the Adoptive T-Cell Therapy Against Solid Tumor.
Jiang Q; Zhang C; Wang H; Peng T; Zhang L; Wang Y; Han W; Shi C
Front Oncol; 2019; 9():1196. PubMed ID: 31781498
[TBL] [Abstract][Full Text] [Related]
27. Advances of functional nanomaterials for cancer immunotherapeutic applications.
Hao Y; Zhou X; Li R; Song Z; Min Y
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1574. PubMed ID: 31566896
[TBL] [Abstract][Full Text] [Related]
28. The Angiopoietin-2 and TIE Pathway as a Therapeutic Target for Enhancing Antiangiogenic Therapy and Immunotherapy in Patients with Advanced Cancer.
Leong A; Kim M
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33217955
[TBL] [Abstract][Full Text] [Related]
29. Triggering Immune System With Nanomaterials for Cancer Immunotherapy.
Li Q; Liu Y; Huang Z; Guo Y; Li Q
Front Bioeng Biotechnol; 2022; 10():878524. PubMed ID: 35497343
[TBL] [Abstract][Full Text] [Related]
30. The Application of and Strategy for Gold Nanoparticles in
He JS; Liu SJ; Zhang YR; Chu XD; Lin ZB; Zhao Z; Qiu SH; Guo YG; Ding H; Pan YL; Pan JH
Front Pharmacol; 2021; 12():687399. PubMed ID: 34163367
[TBL] [Abstract][Full Text] [Related]
31. Advances in Nanomaterials for Immunotherapeutic Improvement of Cancer Chemotherapy.
Liu J; Li B; Li L; Ming X; Xu ZP
Small; 2024 May; ():e2403024. PubMed ID: 38773882
[TBL] [Abstract][Full Text] [Related]
32. Recent Advances in 2D Material-Mediated Immuno-Combined Cancer Therapy.
Ma B; Bianco A
Small; 2021 Nov; 17(46):e2102557. PubMed ID: 34510729
[TBL] [Abstract][Full Text] [Related]
33. Recent progress in stimuli-responsive nanosystems for inducing immunogenic cell death.
Banstola A; Poudel K; Kim JO; Jeong JH; Yook S
J Control Release; 2021 Sep; 337():505-520. PubMed ID: 34314800
[TBL] [Abstract][Full Text] [Related]
34. Cancer-Immunity Cycle and Therapeutic Interventions- Opportunities for Including Pet Dogs With Cancer.
Von Rueden SK; Fan TM
Front Oncol; 2021; 11():773420. PubMed ID: 34869014
[TBL] [Abstract][Full Text] [Related]
35. Current applications and future prospects of nanotechnology in cancer immunotherapy.
Yan S; Zhao P; Yu T; Gu N
Cancer Biol Med; 2019 Aug; 16(3):486-497. PubMed ID: 31565479
[TBL] [Abstract][Full Text] [Related]
36. Nanosonosensitizers With Ultrasound-Induced Reactive Oxygen Species Generation for Cancer Sonodynamic Immunotherapy.
Cheng D; Wang X; Zhou X; Li J
Front Bioeng Biotechnol; 2021; 9():761218. PubMed ID: 34660560
[TBL] [Abstract][Full Text] [Related]
37. Nanomaterials for modulating innate immune cells in cancer immunotherapy.
Le QV; Yang G; Wu Y; Jang HW; Shokouhimehr M; Oh YK
Asian J Pharm Sci; 2019 Jan; 14(1):16-29. PubMed ID: 32104435
[TBL] [Abstract][Full Text] [Related]
38. Role of nanoparticle-mediated immunogenic cell death in cancer immunotherapy.
Sun Y; Feng X; Wan C; Lovell JF; Jin H; Ding J
Asian J Pharm Sci; 2021 Mar; 16(2):129-132. PubMed ID: 33995609
[TBL] [Abstract][Full Text] [Related]
39. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
[TBL] [Abstract][Full Text] [Related]
40. An emerging role for nanomaterials in increasing immunogenicity of cancer cell death.
Mishchenko T; Mitroshina E; Balalaeva I; Krysko O; Vedunova M; Krysko DV
Biochim Biophys Acta Rev Cancer; 2019 Jan; 1871(1):99-108. PubMed ID: 30528646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
